Leading Part D Sponsor

We represented a leading Part D sponsor in civil investigations by the DOJ into whether its mail order pharmacy received inflated payments from Medicare Part D as a result of its drug-dosage form dispensing practices, and into the prior authorization requirements the managed care company imposes on pharmacies that dispense specialty drugs to Medicare beneficiaries. The DOJ closed the inquiry against our client without taking any action.